Reason for request

Inclusion

-


Clinical Benefit

Substantial

Substantial


Clinical Added Value

minor

EFFALA 8 mg, medicated plaster, offers a minor improvement in actual benefit (IAB IV) in terms of efficacy in comparison with cryotherapy.


Contact Us

Évaluation des médicaments

See also